| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 653291 | 64738 | CITALOPRAM TEVA-RATIOPHARM 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CITALOPRAM TEVA-RATIOPHARM 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64738/64738_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64738/64738_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2002-04-30 | 1 | 1 | 1 | 2002-04-30 | 2006-06-19 | 1 | 2011-10-07 | 729699, 999966, 653086 | View Edit Delete | |||||||||||
| 653298 | 64054 | ENALAPRIL/HIDROCLOROTIAZIDA TEVA-RATIOPHARM 20 mg/ 12, 5 mg COMPRIMIDOS EFG | ENALAPRIL/HIDROCLOROTIAZIDA TEVA-RATIOPHARM 20 mg/ 12, 5 mg COMPRIMIDOS EFG, 28 comprimidos | 20 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64054/64054_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64054/64054_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2001-07-11 | 1 | 1 | 1 | 2001-07-11 | 2006-06-19 | 1 | 2011-10-07 | 909879, 999848 | View Edit Delete | |||||||||||
| 653829 | 67013 | BISOPROLOL TEVA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BISOPROLOL TEVA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | 10 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67013/67013_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67013/67013_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2005-09-13 | 1 | 1 | 1 | 2005-09-13 | 2006-02-15 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 653876 | 67579 | CITALOPRAM TEVA-RIMAFAR 30 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CITALOPRAM TEVA-RIMAFAR 30 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67579/67579_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67579/67579_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2006-02-22 | 1 | 1 | 1 | 2006-02-22 | 2006-02-22 | 1 | 2011-02-18 | View Edit Delete | ||||||||||||
| 653880 | 67581 | CITALOPRAM TEVA-RATIOPHARM 30 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CITALOPRAM TEVA-RATIOPHARM 30 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67581/67581_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67581/67581_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2006-02-22 | 1 | 1 | 1 | 2006-02-22 | 2006-02-22 | 1 | 2019-05-13 | View Edit Delete | ||||||||||||
| 653982 | 67614 | EBASTINA TEVA GROUP 20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EBASTINA TEVA GROUP 20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 20 comprimidos | 20 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67614/67614_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67614/67614_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2006-03-16 | 1 | 1 | 1 | 2006-03-16 | 2006-03-16 | 1 | 2023-12-26 | View Edit Delete | ||||||||||||
| 653983 | 67615 | EBASTINA TEVA GROUP 10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EBASTINA TEVA GROUP 10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 20 comprimidos | 10 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67615/67615_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67615/67615_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2006-03-16 | 1 | 1 | 1 | 2006-03-16 | 2006-03-16 | 1 | 2023-12-26 | View Edit Delete | ||||||||||||
| 654405 | 67810 | EBASTINA TEVA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EBASTINA TEVA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 20 comprimidos | 10 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67810/67810_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67810/67810_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2006-05-17 | 1 | 1 | 1 | 2006-05-17 | 2006-05-17 | 1 | 2019-02-14 | View Edit Delete | ||||||||||||
| 654406 | 67811 | EBASTINA TEVA 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EBASTINA TEVA 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 20 comprimidos | 20 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67811/67811_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67811/67811_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2006-05-17 | 1 | 1 | 1 | 2006-05-17 | 2006-05-17 | 1 | 2019-02-14 | View Edit Delete | ||||||||||||
| 654642 | 67900 | IBUPROFENO TEVA 400 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | IBUPROFENO TEVA 400 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 400 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67900/67900_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67900/67900_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2006-06-28 | 1 | 1 | 1 | 2006-06-28 | 2006-06-28 | 1 | 2020-09-14 | View Edit Delete | ||||||||||||
| 653447 | 66404 | OCTAGAMOCTA 50 MG/ML SOLUCION PARA PERFUSION | OCTAGAMOCTA 50 MG/ML SOLUCION PARA PERFUSION , 1 vial de 50 ml | 50 mg/ml inyectable 50 ml | 6 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66404/66404_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66404/66404_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5237 | OCTAPHARMA S.A. | 2004-10-20 | 1 | 1 | 1 | 2004-10-20 | 2007-01-24 | 0 | 2011-06-02 | 650306 | View Edit Delete | |||||||||||
| 653448 | 66404 | OCTAGAMOCTA 50 MG/ML SOLUCION PARA PERFUSION | OCTAGAMOCTA 50 MG/ML SOLUCION PARA PERFUSION , 1 vial de 100 ml | 50 mg/ml inyectable perfusión 100 ml | 6 | 1 | 34 | 1 vial de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66404/66404_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66404/66404_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5237 | OCTAPHARMA S.A. | 2004-10-20 | 1 | 1 | 1 | 2004-10-20 | 2007-01-24 | 0 | 2011-06-02 | 650307 | View Edit Delete | |||||||||||
| 653449 | 66404 | OCTAGAMOCTA 50 MG/ML SOLUCION PARA PERFUSION | OCTAGAMOCTA 50 MG/ML SOLUCION PARA PERFUSION , 1 vial de 200 ml | 50 mg/ml inyectable perfusión 200 ml | 6 | 1 | 34 | 1 vial de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66404/66404_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66404/66404_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5237 | OCTAPHARMA S.A. | 2004-10-20 | 1 | 1 | 1 | 2004-10-20 | 2007-01-24 | 0 | 2011-06-02 | 650308 | View Edit Delete | |||||||||||
| 652649 | 67208 | NOVAG TUSS 10mg/5ml SOLUCION ORAL | NOVAG TUSS 10mg/5ml SOLUCION ORAL, 1 frasco de 200 ml | 2 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67208/67208_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67208/67208_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2006-01-13 | 1 | 1 | 1 | 2006-01-13 | 2006-01-13 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 652928 | 67355 | LANSOPRAZOL TARBIS 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL TARBIS 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 15 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67355/67355_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67355/67355_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2005-12-13 | 1 | 1 | 1 | 2005-12-13 | 2005-12-13 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 652930 | 67356 | LANSOPRAZOL TARBIS 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL TARBIS 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 30 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67356/67356_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67356/67356_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2005-12-13 | 1 | 1 | 1 | 2005-12-13 | 2005-12-13 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 653502 | 42666 | MAXIDEX 1 MG/ML COLIRIO EN SUSPENSIÓN | MAXIDEX 1 MG/ML COLIRIO EN SUSPENSIÓN , 1 frasco de 5 ml | 1 mg/ml | 6 | 5 | 26 | 1 frasco de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/42666/42666_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/42666/42666_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1966-03-01 | 1 | 1 | 1 | 1966-03-01 | 2012-02-27 | 1 | 2013-01-03 | 784157, 672093 | View Edit Delete | |||||||||||
| 653833 | 56799 | SANDIMMUN NEORAL 100 mg/ml SOLUCION ORAL | SANDIMMUN NEORAL 100 mg/ml SOLUCION ORAL , 1 frasco de 50 ml con jeringa dosificadora | 100 mg/ml | 6 | 50 | 26 | 1 frasco de 50 ml con jeringa dosificadora | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/56799/56799_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/56799/56799_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1985-12-01 | 1 | 1 | 1 | 1985-12-01 | 2012-03-27 | 1 | 2013-01-03 | 677658, 966549, 662452 | View Edit Delete | |||||||||||
| 653279 | 33488 | HALOPERIDOL PRODES 2mg/ml GOTAS ORALES EN SOLUCION | HALOPERIDOL PRODES 2mg/ml GOTAS ORALES EN SOLUCION , 1 frasco de 30 ml | 2 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/33488/33488_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/33488/33488_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 1960-02-01 | 1 | 1 | 1 | 1960-02-01 | 1997-05-01 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 654625 | 41455 | GLUTAFERRO 170 MG/ML GOTAS ORALES EN SOLUCIÓN | GLUTAFERRO 170 MG/ML GOTAS ORALES EN SOLUCIÓN , 1 frasco de 25 ml | 30 mg/ml | 6 | 25 | 26 | 1 frasco de 25 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/41455/41455_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/41455/41455_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8323 | MEDIX S.A. | 1985-09-01 | 1 | 1 | 1 | 1985-09-01 | 2012-09-07 | 1 | 2013-01-03 | 803502, 650113, 656691, 663320 | View Edit Delete |
Page 102 of 1036, showing 20 records out of 20709 total, starting on record 2021, ending on 2040